Fluid is a Stanford University spinout company that enables users to track and diagnose influenza and other infectious disease using their mobile phone. Fluid's technology combines user-collected information with large healthcare datasets to create personalized risk assessments.

The current explosion of public health data represents a turning point in health information. However, in its current form, much of this data is inaccessible to everyday people. Fluid's platform combines personalized, user-collected data with real-time public information on infectious disease to improve awareness, enhance behavior, and enable more people to benefit from clinical treatment.

Join our email list:

| who we are |

Adam is an entrepreneur focused on technology and business development in mobile health.

Previously at Google X and Harvard, he is inventor on nine patents and author of ten publications on point-of-care diagnostics. Adam co-developed the core technologies of Claros Diagnostics (acquired by Opko in 2011) and nonprofit Diagnostics-For-All, which raised $10 M from the Bill & Melinda Gates Foundation.

He is the founding investor in new companies which have raised more than $70 M in follow-on financing. Most recently, Micah has been a seed-stage investor and adviser to BioImagene (acquired in 2010 by Roche for $100 M in cash), Stack Exchange, Hadapt, and Judicata.